ASMB (ASMB) Stock Price & Analysis
ASMB (ASMB) rose 0.00% to USD 25.55 as of July 25, 2026 at 04:20 UTC, according to Nexqual real-time market data.
ASMB last closed at USD 25.55; the session ranged USD 24.85–26.53 on volume of 141,177 shares. Market capitalization is —, with a 52-week range of USD 16.9–39.71 (NMS). Source: Nexqual, July 25, 2026 at 04:20 UTC.
Key Statistics (as of July 25, 2026 at 04:20 UTC)
| Price | USD 25.55 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 25.55 |
| Open | USD 25.55 |
| Day Range | USD 24.85 – 26.53 |
| 52-Week Range | USD 16.9 – 39.71 |
| Volume | 141,177 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ASMB)
Nexqual's technical model rates ASMB "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:20 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.77 (neutral) |
| vs SMA50 | Below (USD 26.19) |
| MACD | -0.13 (negative) |
From ASMB's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | USD 3.24 | ▼ 2.7% |
| ANAB | AnaptysBio, Inc. | USD 54.15 | ▲ 2.93% |
| NXTC | NextCure, Inc. | USD 4.24 | ▼ 3.64% |
| ATRA | Atara Biotherapeutics, Inc. | USD 7.9 | ▼ 2.77% |
| APRE | Aprea Therapeutics, Inc. | USD 0.63 | ▼ 4.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:20 UTC. This page is informational and not investment advice.